Healthcare provider profile · identity verified

Jacob Mitchell, PA-C

Physician Assistant · DALLAS, OR · NPI 1598250292

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	593	167
Levothyroxine Sodium	Levothyroxine Sodium	350	92
Amlodipine Besylate	Amlodipine Besylate	297	85
Losartan Potassium	Losartan Potassium	278	78
Lisinopril	Lisinopril	254	79
Metformin Hcl	Metformin Hcl	222	66
Hydrochlorothiazide	Hydrochlorothiazide	162	51
Tamsulosin Hcl	Tamsulosin Hcl	160	46
Pantoprazole Sodium	Pantoprazole Sodium	156	49
Metoprolol Succinate	Metoprolol Succinate	155	46
Omeprazole	Omeprazole	155	52
Gabapentin	Gabapentin	148	50
Furosemide	Furosemide	143	39
Potassium Chloride	Potassium Chloride	142	42
Albuterol Sulfate Hfa	Albuterol Sulfate	122	48
Jardiance	Empagliflozin	105	29
Simvastatin	Simvastatin	98	31
Eliquis	Apixaban	97	26
Citalopram Hbr	Citalopram Hydrobromide	94	22
Escitalopram Oxalate	Escitalopram Oxalate	91	28
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	86	33
Rosuvastatin Calcium	Rosuvastatin Calcium	85	24
Trazodone Hcl	Trazodone Hcl	83	22
Metoprolol Tartrate	Metoprolol Tartrate	73	22
Carvedilol	Carvedilol	70	21
Fluoxetine Hcl	Fluoxetine Hcl	68	17
Fluticasone Propionate	Fluticasone Propionate	68	26
Tizanidine Hcl	Tizanidine Hcl	65	15
Metformin Hcl Er	Metformin Hcl	63	21
Warfarin Sodium	Warfarin Sodium	62	15
Pioglitazone Hcl	Pioglitazone Hcl	61	13
Pravastatin Sodium	Pravastatin Sodium	59	21
Duloxetine Hcl	Duloxetine Hcl	57	18
Allopurinol	Allopurinol	56	18
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	55	14
Sertraline Hcl	Sertraline Hcl	54	19
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	52	13
Mirtazapine	Mirtazapine	52	14
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	51	12
Meloxicam	Meloxicam	50	18
Oxybutynin Chloride Er	Oxybutynin Chloride	50	suppressed
Alendronate Sodium	Alendronate Sodium	49	15
Clopidogrel	Clopidogrel Bisulfate	47	18
Famotidine	Famotidine	47	14
Glimepiride	Glimepiride	46	suppressed
Glipizide Er	Glipizide	46	16
Ozempic	Semaglutide	45	11
Finasteride	Finasteride	43	12
Pregabalin	Pregabalin	41	14
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	40	12
Prednisone	Prednisone	38	26
Bupropion Xl	Bupropion Hcl	34	suppressed
Alprazolam	Alprazolam	33	15
Isosorbide Mononitrate Er	Isosorbide Mononitrate	33	suppressed
Ropinirole Hcl	Ropinirole Hcl	32	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	31	suppressed
Montelukast Sodium	Montelukast Sodium	30	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	28	26
Clonazepam	Clonazepam	28	suppressed
Oxycodone Hcl	Oxycodone Hcl	28	suppressed
Terazosin Hcl	Terazosin Hcl	28	suppressed
Tramadol Hcl	Tramadol Hcl	28	suppressed
Atenolol	Atenolol	27	suppressed
Ezetimibe	Ezetimibe	27	suppressed
Mounjaro	Tirzepatide	27	suppressed
Nystatin	Nystatin	27	13
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	27	suppressed
Methocarbamol	Methocarbamol	26	suppressed
Lovastatin	Lovastatin	25	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	25	23
Cephalexin	Cephalexin	24	22
Chlorthalidone	Chlorthalidone	24	suppressed
Ibuprofen	Ibuprofen	24	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	23	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	23	21
Venlafaxine Hcl Er	Venlafaxine Hcl	23	suppressed
Naproxen	Naproxen	22	14
Nortriptyline Hcl	Nortriptyline Hcl	22	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	21	12
Trulicity	Dulaglutide	21	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	20	suppressed
Latanoprost	Latanoprost	20	suppressed
Paroxetine Hcl	Paroxetine Hcl	20	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	20	17
Bupropion Hcl Sr	Bupropion Hcl	19	suppressed
Estradiol	Estradiol	19	suppressed
Xarelto	Rivaroxaban	19	suppressed
Donepezil Hcl	Donepezil Hcl	18	suppressed
Farxiga	Dapagliflozin Propanediol	18	suppressed
Novolog Flexpen	Insulin Aspart	18	suppressed
Acyclovir	Acyclovir	17	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	17	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	17	suppressed
Spironolactone	Spironolactone	17	suppressed
Valacyclovir	Valacyclovir Hcl	17	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	17	suppressed
Vascepa	Icosapent Ethyl	16	suppressed
Buspirone Hcl	Buspirone Hcl	15	suppressed
Fluconazole	Fluconazole	15	11
Hydroxyzine Pamoate	Hydroxyzine Pamoate	15	suppressed
Tresiba Flextouch U-200	Insulin Degludec	15	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	14	13
Clonidine Hcl	Clonidine Hcl	14	suppressed
Lamotrigine	Lamotrigine	14	suppressed
Symbicort	Budesonide/Formoterol Fumarate	14	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	14	suppressed
Anastrozole	Anastrozole	13	suppressed
Baclofen	Baclofen	13	suppressed
Doxepin Hcl	Doxepin Hcl	13	suppressed
Myrbetriq	Mirabegron	13	suppressed
Synthroid	Levothyroxine Sodium	13	suppressed
Ventolin Hfa	Albuterol Sulfate	13	suppressed
Breyna	Budesonide/Formoterol Fumarate	12	suppressed
Methimazole	Methimazole	12	suppressed
Ofloxacin	Ofloxacin	12	11
Quetiapine Fumarate	Quetiapine Fumarate	12	suppressed
Qvar Redihaler	Beclomethasone Dipropionate	12	suppressed
Topiramate	Topiramate	12	suppressed
Benazepril Hcl	Benazepril Hcl	11	suppressed
Febuxostat	Febuxostat	11	suppressed
Lansoprazole	Lansoprazole	11	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	11	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	11	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error